BACLOFEN vs TIZANIDINE

Compare BACLOFEN (BACLOFEN) and TIZANIDINE (tizanidine) — clinical data, side effects, and patient experiences.

BACLOFEN

BACLOFEN · Other

How it works

Other agent

Approved for

INDICATIONS AND USAGE Baclofen tablets

USP are useful for the alleviation of signs and symptoms of spasticity resulting from multiple sclerosis

particularly for the relief of flexor spasms and concomitant pain

clonus

OralTablet

TIZANIDINE

tizanidine · Other

How it works

Other agent

Approved for

1 INDICATIONS AND USAGE Tizanidine is indicated for the treatment of spasticity in adults. Tizanidine is a central alpha-2-adrenergic agonist indicated for the treatment of spasticity. (1)

OralTablet

Quick Comparison

BACLOFENTIZANIDINE

Drug Class

Other

Route

Oral

Half-Life

—

FDA Approved

—

Side Effect Frequency Comparison

Estimated frequency (%) based on clinical trial data

Side Effects

BACLOFEN

Fatigue

1-10%

Drug Not Working

1-10%

Falls

1-10%

Nausea

1-10%

Headache

1-10%

Dizziness

1-10%

UTI

1-10%

Weakness

1-10%

TIZANIDINE

Fatigue

>10%

Nausea

1-10%

Drug Not Working

1-10%

Headache

1-10%

Falls

1-10%

Diarrhea

1-10%

Dizziness

1-10%

Shortness of Breath

1-10%

FDA Warnings

BACLOFEN

If the potential benefit justifies the potential risk to the fetus and oral baclofen is continued during pregnancy, gradua ly reduce the dose and discontinue baclofen before delivery
Therefore, except for serious adverse reactions, the dose should be reduced slowly when the drug is discontinued
Baclofen should be used during pregnancy only if the benefit clearly justifies the potential risk to the fetus

TIZANIDINE

5 WARNINGS AND PRECAUTIONS Hypotension: monitor for signs and symptoms of hypotension, in particular in patients receiving concurrent antihypertensives; tizanidine should not be used with other α 2 -adrenergic agonists ( 5
5 ) Risk of liver injury: monitor ALTs; discontinue tizanidine if liver injury occurs ( 5
The risk of hypotension may be minimized by dose titration; monitoring for signs and symptoms of hypotension prior to dosage increase may minimize the risks associated with hypotension
In addition, patients moving from a supine to fixed upright position may be at increased risk for hypotension and orthostatic effects

Clinical Trial Data

No head-to-head clinical studies found for BACLOFEN vs TIZANIDINE.

BACLOFEN vs TIZANIDINE: What You Should Know

Key Differences

Both BACLOFEN and TIZANIDINE belong to the Other class. While they share a similar mechanism of action, differences in pharmacokinetics, dosing, and side effect profiles may make one more suitable than the other for individual patients.

Safety Considerations

BACLOFEN carries 3 FDA warnings. TIZANIDINE carries 4 FDA warnings. Patients should discuss all warnings and contraindications with their healthcare provider before starting or switching medications..

This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.

Related Comparisons

BACLOFEN vs GABAPENTIN→GABAPENTIN vs TIZANIDINE→BACLOFEN vs PREGABALIN→PREGABALIN vs TIZANIDINE→BACLOFEN vs DULOXETINE→DULOXETINE vs TIZANIDINE→

Loading comparison data...

BACLOFEN vs TIZANIDINE

Compare BACLOFEN (BACLOFEN) and TIZANIDINE (tizanidine) — clinical data, side effects, and patient experiences.

BACLOFEN

BACLOFEN · Other

How it works

Other agent

Approved for

INDICATIONS AND USAGE Baclofen tablets

USP are useful for the alleviation of signs and symptoms of spasticity resulting from multiple sclerosis

particularly for the relief of flexor spasms and concomitant pain

clonus

OralTablet

TIZANIDINE

tizanidine · Other

How it works

Other agent

Approved for

1 INDICATIONS AND USAGE Tizanidine is indicated for the treatment of spasticity in adults. Tizanidine is a central alpha-2-adrenergic agonist indicated for the treatment of spasticity. (1)

OralTablet

Quick Comparison

BACLOFENTIZANIDINE

Drug Class

Other

Route

Oral

Half-Life

—

FDA Approved

—

Side Effect Frequency Comparison

Estimated frequency (%) based on clinical trial data

Side Effects

BACLOFEN

Fatigue

1-10%

Drug Not Working

1-10%

Falls

1-10%

Nausea

1-10%

Headache

1-10%

Dizziness

1-10%

UTI

1-10%

Weakness

1-10%

TIZANIDINE

Fatigue

>10%

Nausea

1-10%

Drug Not Working

1-10%

Headache

1-10%

Falls

1-10%

Diarrhea

1-10%

Dizziness

1-10%

Shortness of Breath

1-10%

FDA Warnings

BACLOFEN

If the potential benefit justifies the potential risk to the fetus and oral baclofen is continued during pregnancy, gradua ly reduce the dose and discontinue baclofen before delivery
Therefore, except for serious adverse reactions, the dose should be reduced slowly when the drug is discontinued
Baclofen should be used during pregnancy only if the benefit clearly justifies the potential risk to the fetus

TIZANIDINE

5 WARNINGS AND PRECAUTIONS Hypotension: monitor for signs and symptoms of hypotension, in particular in patients receiving concurrent antihypertensives; tizanidine should not be used with other α 2 -adrenergic agonists ( 5
5 ) Risk of liver injury: monitor ALTs; discontinue tizanidine if liver injury occurs ( 5
The risk of hypotension may be minimized by dose titration; monitoring for signs and symptoms of hypotension prior to dosage increase may minimize the risks associated with hypotension
In addition, patients moving from a supine to fixed upright position may be at increased risk for hypotension and orthostatic effects

Clinical Trial Data

No head-to-head clinical studies found for BACLOFEN vs TIZANIDINE.

BACLOFEN vs TIZANIDINE: What You Should Know

Key Differences

Safety Considerations

This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.